Complete response with pegylated liposomal doxorubicin as a second-line therapy in metastatic ovarian carcinosarcoma: Significance of assessment of the response by FDG-PET

  1. Gómez-Raposo, C.
  2. López-Gómez, M.
  3. Sereno, M.
  4. Zambrana, F.
  5. Casado, E.
Journal:
Gynecologic Oncology Reports

ISSN: 2211-338X

Year of publication: 2012

Volume: 2

Issue: 2

Pages: 67-68

Type: Article

DOI: 10.1016/J.GYNOR.2012.02.004 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus